Dr. Vlad Bogin, Cromos Pharma CEO, led the panel discussion “Clinical Trials for Small Sponsors”. He was joined by Kevin M. Crawford (Head of Clinical Operations, Tenax Therapeutics), Matt Dickason (COO, ImmunogenX) and April Weir-Hauptman (Director, InClin).
The well-attended and lively discussion centered around the opportunities and challenges that small biotech companies face as they enter the clinical development phase. Having worked for both large and small organizations the panelists had a unique perspective on the subject. They were well equipped to provide insightful comparative analysis into the differences in budget allocation, vendor management and the significance of reaching the milestones.
Cromos Pharma is an international CRO which is celebrating 15 years in clinical research excellence. Find out more about how Cromos Pharma can add value to your company’s clinical programs by visiting www.cromospharma.com.
Watch this video about Cromos Pharma’s 15 year development and growth.
#CRO #clinicalresearch #CromosPharma15 #leadership #CromosPharma
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.